Licensing in the life sciences industry post MedImmune v Genentech
This is an Insight article, written by a selected partner as part of IAM's co-published content. Read more on Insight
When licensing in the life sciences industry, certain issues require particularly careful consideration and clear drafting. They include the definitions of the licensed product, the royalty base and the royalty term.
Download